Alivus Life Sciences Schedules Q2 FY27 Earnings Conference Call
Alivus Life Sciences Ltd 路 Intimation 路 30 Oct 2026, 8:30 am
Alivus Life Sciences Schedules Q2 FY27 Earnings Conference Call Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) will host its Q2 FY27 earnings conference call on Friday, 30th Oct'26, from 8:30 a.m. to 9:30 a.m. IST to discuss financial performance. Universal dial-in numbers for participants are +91 22 6280 1564 and +91 22 7115 8394, alongside international toll-free and toll access across key global locations including the USA, UK, Singapore, Hong Kong, and Japan. Pre-registration is available, with investor relations managed via Ernst & Young.
Original exchange filing (PDF)
More announcements from Alivus Life Sciences Ltd
- Enclosed please find herewith update on acquisition. 路 11 Nov 2026
- Please find enclosed herewith disclosure under Regulation 30 of SEBI(LODR), 2015. 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirma Ltd 路 07 Nov 2026
- Please find attached herewith submission with respect to transcript of the earning call. 路 06 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor meeting. 路 04 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor Meet. 路 30 Oct 2026
- We hereby confirm that we have uploaded audio recording of the Q2 FY2027 Earnings Call held on October 30, 2026 on the website of the Company. 路 30 Oct 2026
- Please find enclosed herewith intimation with respect to allotment of equity shares under "Employee Stock Option Scheme, 2021" 路 30 Oct 2026
